ASH 2010: Large International Study Backs Use of Imatinib in Adults With Ph ALL
March 10th 2011Imatinib (Gleevec) improves the ability to proceed with allogeneic stem cell transplantation and improves 5-year overall survival (OS) when used as induction therapy in patients with Philadelphia chromosome positive (Ph ) acute lymphoblastic leukemia